Briacell Therapeutics Corp. (BCTX) Q1 2026 Earnings
BCTX·Reported March 10, 2026·After market close
Diluted EPS came in at $-2.58 (+88.9% YoY), beat the $-4.84 consensus by $2.26.
Diluted EPS
$-2.58beat by $2.26
Consensus: $-4.84
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Briacell Therapeutics Corp.'s Q1 2026 earnings report.
Briacell Therapeutics Corp. (BCTX) reported Q1 2026 earnings on March 10, 2026 after market close.
Briacell Therapeutics Corp. reported diluted EPS of $-2.58 for Q1 2026.
EPS beat the consensus estimate of $-4.84 by $2.26.
Compared to the same quarter a year prior, diluted EPS grew 88.9% from $-23.30.
You can read the 8-K earnings release (0001493152-26-009382) and the 10-Q periodic report (0001493152-26-009557) directly on SEC EDGAR. The filing index links above go to sec.gov.